| Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques M Mandolesi, H Das, L de Vries, Y Yang, C Kim, M Dhinakaran, ... | | 2024 |
| Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features M Juraska, H Bai, AC deCamp, CA Magaret, L Li, K Gillespie, LN Carpp, ... Proceedings of the National Academy of Sciences 121 (4), e2308942121, 2024 | 1 | 2024 |
| Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2 K Lenart, R Arcoverde Cerveira, F Hellgren, S Ols, DJ Sheward, C Kim, ... npj Vaccines 9 (1), 17, 2024 | | 2024 |
| Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic. A Ackerman, C Fichter, T Ison, C Esneau, V Milogiannakis, M Ruiz Silva, ... medRxiv, 2024.04. 18.24305862, 2024 | | 2024 |
| Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2 (preprint) RA Ehling, M Minot, MD Overath, DJ Sheward, J Han, B Gao, JM Taft, ... | | 2024 |
| Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2 RA Ehling, M Minot, MD Overath, DJ Sheward, J Han, B Gao, JM Taft, ... bioRxiv, 2024.03. 28.587189, 2024 | | 2024 |
| Neutralisation sensitivity of the SARS-CoV-2 BA. 2.87. 1 variant DJ Sheward, U Marking, O Bladh, S Held, E Looyens, L Vandenabeele, ... bioRxiv, 2024.03. 21.586176, 2024 | 1 | 2024 |
| Optimized SMRT-UMI protocol produces highly accurate sequence datasets from diverse populations—Application to HIV-1 quasispecies DH Westfall, W Deng, A Pankow, L Chen, H Zhao, C Williamson, ... Virus Evolution 10 (1), veae019, 2024 | 2 | 2024 |
| Full-spike deep mutational scanning helps predict the evolutionary success of SARS-CoV-2 clades B Dadonaite, J Brown, TE McMahon, AG Farrell, D Asarnow, C Stewart, ... bioRxiv, 2023 | 7 | 2023 |
| SARS-CoV-2 evolution in the Omicron era C Roemer, DJ Sheward, R Hisner, F Gueli, H Sakaguchi, N Frohberg, ... Nature microbiology 8 (11), 1952-1959, 2023 | 25 | 2023 |
| Sensitivity of the SARS-CoV-2 BA. 2.86 variant to prevailing neutralising antibody responses DJ Sheward, Y Yang, M Westerberg, S Öling, S Muschiol, K Sato, ... The Lancet Infectious Diseases 23 (11), e462-e463, 2023 | 46 | 2023 |
| Antigen receptor stimulation induces purifying selection against pathogenic mitochondrial tRNA mutations J Zhang, C Koolmeister, J Han, R Filograna, L Hanke, M Àdori, ... JCI insight 8 (17), 2023 | 1 | 2023 |
| Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study L Vikström, P Fjällström, YD Gwon, DJ Sheward, J Wigren-Byström, ... The Lancet Regional Health–Europe 30, 2023 | 9 | 2023 |
| Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies C Joyce, S Murrell, B Murrell, O Omorodion, LS Ver, N Carrico, R Bastidas, ... PLoS pathogens 19 (6), e1011416, 2023 | 2 | 2023 |
| Evaluation of archival HIV DNA in brain and lymphoid tissues MF Oliveira, A Pankow, T Vollbrecht, NM Kumar, G Cabalero, C Ignacio, ... Journal of Virology 97 (6), e00543-23, 2023 | 4 | 2023 |
| Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages M Chernyshev, M Sakharkar, RI Connor, HL Dugan, DJ Sheward, ... Nature Communications 14 (1), 2249, 2023 | 5 | 2023 |
| Emergence and antibody evasion of BQ, BA. 2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level A Akerman, V Milogiannakis, T Jean, C Esneau, MR Silva, T Ison, ... EBioMedicine 90, 2023 | 23 | 2023 |
| A Multiparametric and High-Throughput Platform for Host–Virus Binding Screens J Schlegel, B Porebski, L Andronico, L Hanke, S Edwards, H Brismar, ... Nano Letters 23 (9), 3701-3707, 2023 | 1 | 2023 |
| Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses P Pushparaj, A Nicoletto, X Castro Dopico, DJ Sheward, S Kim, S Ekström, ... Frontiers in virology 3, 1128253, 2023 | 3 | 2023 |
| Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes C Dufour, C Richard, M Pardons, M Massanella, A Ackaoui, B Murrell, ... Nature Communications 14 (1), 1115, 2023 | 19 | 2023 |
Daniel ShewardKarolinska InstitutetVerified email at ki.se
